BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35441812)

  • 1. Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms.
    Li JB; Ke KJ; Zhang WL; Wang LY; Wu YP; Weng F; Tian H; Qiu ZY; Li Y; Lin SY; Ye MX; Ou QJ; Gong CH; Lu ZH; Pan ZZ; Wan DS; Peng JH; Fang YJ
    Cancer Med; 2022 Nov; 11(22):4321-4331. PubMed ID: 35441812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors associated with positive predictive value of preliminary screening in a two-step screening strategy for colorectal neoplasms in China.
    Li JB; Qiu ZY; Deng YX; Li Y; Lin ZC; Wu YP; Weng F; Tian H; Ou QJ; Gong CH; Pan ZZ; Wan DS; Peng JH; Fang YJ
    Discov Oncol; 2022 Jan; 13(1):4. PubMed ID: 35201502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postponing colonoscopy for 6 months in high-risk population increases colorectal cancer detection in China.
    Zhang M; Zhang Y; Zhang W; Zhao L; Jing H; Wu X; Guo L; Zhang H; Zhang Y; Zhu S; Zhang S; Zhang X
    Cancer Med; 2023 May; 12(10):11816-11827. PubMed ID: 36951442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for colorectal cancer in Tianhe, Guangzhou: results of combining fecal immunochemical tests and risk factors for selecting patients requiring colonoscopy.
    Liao Y; Li S; Chen C; He X; Lin F; Wang J; Yang Z; Lan P
    Gastroenterol Rep (Oxf); 2018 May; 6(2):132-136. PubMed ID: 29780602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of a colorectal cancer screening protocol in an economically and medically underserved population.
    Cai SR; Zhang SZ; Zhu HH; Huang YQ; Li QR; Ma XY; Yao KY; Zheng S
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1572-9. PubMed ID: 21952582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age- and sex-stratified detection rates and associated factors of colorectal neoplasia in the Tianjin colorectal cancer screening program from 2012 to 2020.
    Yuan Z; Wang S; Wang Y; Li H; Gao W; Liu X; Han Y; Liu Z; Zhang Q; Ma H; Wang J; Wei X; Zhang X; Cui W; Zhang C
    BMC Gastroenterol; 2023 Dec; 23(1):435. PubMed ID: 38087194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Evaluation of Preliminary Screening Methods for Colorectal Cancer in a Mass Program.
    Ye D; Huang Q; Li Q; Jiang X; Mamat M; Tang M; Wang J; Chen K
    Dig Dis Sci; 2017 Sep; 62(9):2532-2541. PubMed ID: 28634645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study).
    González-López N; Quintero E; Gimeno-Garcia AZ; Bujanda L; Banales J; Cubiella J; Salve-Bouzo M; Herrero-Rivas JM; Cid-Delgado E; Alvarez-Sanchez V; Ledo-Rodríguez A; de-Castro-Parga ML; Fernández-Poceiro R; Sanromán-Álvarez L; Santiago-Garcia J; Herreros-de-Tejada A; Ocaña-Bombardo T; Balaguer F; Rodríguez-Soler M; Jover R; Ponce M; Alvarez-Urturi C; Bessa X; Roncales MP; Sopeña F; Lanas A; Nicolás-Pérez D; Adrián-de-Ganzo Z; Carrillo-Palau M; González-Dávila E;
    PLoS Med; 2023 Oct; 20(10):e1004298. PubMed ID: 37874831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study.
    Bertels L; Lucassen P; van Asselt K; Dekker E; van Weert H; Knottnerus B
    Scand J Prim Health Care; 2020 Dec; 38(4):487-498. PubMed ID: 33185121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Scoring Systems for Predicting the Presence of Colorectal Neoplasia by Fecal Immunochemical Test Results in Chinese Population.
    Wu W; Chen X; Fu C; Wong MCS; Bao P; Huang J; Gong Y; Xu W; Gu K
    Clin Transl Gastroenterol; 2022 Oct; 13(10):e00525. PubMed ID: 36007185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world application of a fast stool DNA test for colorectal cancer screening in primary screening positive population.
    Zhu Y; Zhao G; Ma W; Chen X; Chen X; Li D; Zhao S; Xiong S; Zheng M
    Cancer Med; 2023 Apr; 12(7):7689-7698. PubMed ID: 36468523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Participation rate and detection of colorectal neoplasms based on multi-round fecal immunochemical testing for colorectal cancer screening in the Chinese population].
    Li N; Zhou YY; Lu M; Zhang YH; Lu B; Luo CY; Luo JH; Cai J; Chen HD; Dai M
    Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1041-1050. PubMed ID: 38110312
    [No Abstract]   [Full Text] [Related]  

  • 15. Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study.
    Zhang M; Zhao L; Zhang Y; Jing H; Wei L; Li Z; Zhang H; Zhang Y; Zhu S; Zhang S; Zhang X
    Front Oncol; 2022; 12():893183. PubMed ID: 35712520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.
    de Klerk CM; Vendrig LM; Bossuyt PM; Dekker E
    Am J Gastroenterol; 2018 Dec; 113(12):1778-1787. PubMed ID: 30158713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal neoplasia prevalence in a predominantly Hispanic community: Results from a colorectal cancer screening program in Texas.
    Willauer AN; Zuckerman MJ; Alomari A; Alvarado LA; Salaiz R; Casner N; Dwivedi AK; Shokar NK
    Am J Med Sci; 2022 Oct; 364(4):394-403. PubMed ID: 35398033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining fecal immunochemical testing and questionnaire-based risk assessment in selecting participants for colonoscopy screening in the Chinese National Colorectal Cancer Screening Programs: A population-based cohort study.
    Dong X; Du L; Luo Z; Xu Y; Wang C; Wang F; Cao W; Zhao L; Zheng Y; Zhu H; Xia C; Li J; Du M; Hang D; Ren J; Shi J; Shen H; Chen W; Li N; He J;
    PLoS Med; 2024 Feb; 21(2):e1004340. PubMed ID: 38386617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015-2016.
    Almansoori A; Alzaabi M; Alketbi L
    BMC Cancer; 2021 Aug; 21(1):897. PubMed ID: 34362343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.